JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
PUT
Signet Jewelers
SIG
$4B
| $2.29M | ﹤0.01% |
40,400
| – | – |
2017 Q2
2 quarters
|
|
|
NCI
3102
DELISTED
Navigant Consulting, Inc.
NCI
| $2.28M | ﹤0.01% |
117,259
+28,879
| +33% | +$524K |
2014 Q4
12 quarters
|
|
|
LOXO
3103
CALL
DELISTED
Loxo Oncology, Inc
LOXO
| $2.27M | ﹤0.01% |
+27,000
| New | +$2.25M |
2017 Q4
0 quarters
|
|
|
LOXO
3104
PUT
DELISTED
Loxo Oncology, Inc
LOXO
| $2.27M | ﹤0.01% |
+27,000
| New | +$2.25M |
2017 Q4
0 quarters
|
|
3105
Applied Optoelectronics
AAOI
$9.75B
| $2.26M | ﹤0.01% |
59,824
-63,601
| -52% | -$2.81M |
2016 Q3
5 quarters
|
|
3106
CALL
YPF Sociedad Anonima ADS
YPF
$19.3B
| $2.26M | ﹤0.01% |
98,700
| – | – |
2017 Q2
2 quarters
|
|
|
NE
3107
PUT
DELISTED
Noble Corporation
NE
| $2.26M | ﹤0.01% |
500,000
| – | – |
2015 Q4
8 quarters
|
|
|
TRTX
3108
TPG RE Finance Trust
TRTX
$469M
| $2.26M | ﹤0.01% |
+118,548
| New | +$2.31M |
2017 Q4
0 quarters
|
|
3109
McGrath RentCorp
MGRC
$2.86B
| $2.26M | ﹤0.01% |
48,052
+26,373
| +122% | +$1.22M |
2016 Q4
4 quarters
|
|
3110
CNA Financial
CNA
$12.5B
| $2.26M | ﹤0.01% |
42,524
+18,420
| +76% | +$970K |
2015 Q2
10 quarters
|
|
3111
PUT
Gogo Inc
GOGO
$287M
| $2.26M | ﹤0.01% |
+200,000
| New | +$2.13M |
2017 Q4
0 quarters
|
|
|
RESI
3112
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $2.25M | ﹤0.01% |
189,886
-145,012
| -43% | -$1.6M |
2016 Q4
4 quarters
|
|
3113
Modine Manufacturing
MOD
$9.57B
| $2.25M | ﹤0.01% |
111,332
+71,971
| +183% | +$1.55M |
2016 Q4
4 quarters
|
|
|
EVHC
3114
CALL
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $2.24M | ﹤0.01% |
+64,700
| New | +$2.26M |
2017 Q4
0 quarters
|
|
3115
iShares US Equity Factor ETF
LRGF
$3.73B
| $2.23M | ﹤0.01% |
70,210
+2,582
| +4% | +$80.6K |
2016 Q2
6 quarters
|
|
|
CRAY
3116
DELISTED
Cray, Inc.
CRAY
| $2.23M | ﹤0.01% |
92,202
+72,424
| +366% | +$1.53M |
2015 Q4
8 quarters
|
|
|
SVM
3117
Silvercorp Metals
SVM
$2.32B
| $2.22M | ﹤0.01% |
848,724
+247,051
| +41% | +$630K |
2017 Q2
2 quarters
|
|
3118
iShares Short-Term National Muni Bond ETF
SUB
$11.8B
| $2.21M | ﹤0.01% |
21,048
+8,652
| +70% | +$912K |
2015 Q1
11 quarters
|
|
3119
Trupanion
TRUP
$1.03B
| $2.21M | ﹤0.01% |
75,383
+69,956
| +1,289% | +$2.06M |
2017 Q3
1 quarter
|
|
3120
First Business Financial Services
FBIZ
$589M
| $2.2M | ﹤0.01% |
99,475
-3,725
| -4% | -$84.2K |
2014 Q2
14 quarters
|
|
3121
Rapid7
RPD
$818M
| $2.2M | ﹤0.01% |
117,858
+34,784
| +42% | +$644K |
2015 Q3
9 quarters
|
|
|
LDL
3122
DELISTED
Lydall, Inc.
LDL
| $2.19M | ﹤0.01% |
43,221
+13,387
| +45% | +$733K |
2013 Q2
18 quarters
|
|
|
KLXI
3123
DELISTED
KLX Inc.
KLXI
| $2.19M | ﹤0.01% |
38,081
+37,220
| +4,323% | +$1.79M |
2017 Q1
3 quarters
|
|
3124
Under Armour
UAA
$1.98B
| $2.19M | ﹤0.01% |
151,547
+45,145
| +42% | +$652K |
2013 Q2
18 quarters
|
|
3125
Unilever
UL
$128B
| $2.18M | ﹤0.01% |
35,020
+7,744
| +28% | +$491K |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.